Severe community-acquired bloodstream infection with Acinetobacter ursingii in person who injects drugs

Emerging Infectious Diseases

Volumn 22, Issue 1, 2016, Pages 134-137

  Salzer, Helmut J F ^a,b   Rolling, Thierry ^a   Schmiede, Stefan ^a   Klupp, Eva Maria ^a   Lange, Christoph ^b,c,d,e   Seifert, Harald ^e,f  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Research Center Borstel   (Germany)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF NAMIBIA   (Namibia)

^e HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^f UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; C REACTIVE PROTEIN; CEFTRIAXONE; CIPROFLOXACIN; COCAINE; GENTAMICIN; IMIPENEM; MEROPENEM; RNA 16S; THIENAMYCIN DERIVATIVE;

ACINETOBACTER; ACINETOBACTER INFECTION; ACINETOBACTER URSINGII; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BLOODSTREAM INFECTION; CASE REPORT; CHILL; COMMUNITY ACQUIRED INFECTION; DISEASE SEVERITY; FEMALE; FEVER; FOLLOW UP; GENE SEQUENCE; HEPATITIS C; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ABUSE; LEUKOCYTE COUNT; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEDICAL HISTORY; MIDDLE AGED; NAUSEA; NONHUMAN; RNA GENE; SEQUENCE ANALYSIS; TACHYCARDIA; THORAX RADIOGRAPHY; ACINETOBACTER INFECTIONS; BACTEREMIA; COMMUNITY-ACQUIRED INFECTIONS; DRUG EFFECTS; MICROBIOLOGY; PATHOGENICITY;

ACINETOBACTER; ACINETOBACTER INFECTIONS; BACTEREMIA; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; MIDDLE AGED; THIENAMYCINS;

EID: 84950288068     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2201.151298     Document Type: Article

References (13)

1. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21:538–82. http://dx.doi.org/10.1128/CMR.00058-07
2. Nemec A, De Baere T, Tjernberg I, Vaneechoutte M, van der Reijden TJ, Dijkshoorn L. Acinetobacter ursingii sp. nov. and Acinetobacter schindleri sp. nov. isolated from human clinical specimens. Int J Syst Evol Microbiol. 2001;51:1891–9. http://dx.doi.org/10.1099/00207713-51-5-1891
3. Loubinoux J, Mihaila-Amrouche L, Le Fleche A, Pigne E, Huchon G, Grimont PA, et al. Bacteremia caused by Acinetobacter ursingii. J Clin Microbiol. 2003;41:1337–8. http://dx.doi.org/10.1128/JCM.41.3.1337-1338.2003
4. Horii T, Tamai K, Mitsui M, Notake S, Yanagisawa H. Bloodstream infections caused by Acinetobacter ursingii in an obstetrics ward. Infect Genet Evol. 2011;11:52–6. http://dx.doi.org/10.1016/j.meegid.2010.10.011
5. Kilic A, Li H, Mellmann A, Basustaoglu AC, Kul M, Senses Z, et al. Acinetobacter septicus sp. nov. association with a nosocomial outbreak of bacteremia in a neonatal intensive care unit. J Clin Microbiol. 2008;46:902–8. http://dx.doi.org/10.1128/JCM.01876-07
6. Máder K, Terhes G, Hajdu E, Urban E, Soki J, Magyar T, et al. Outbreak of septicaemic cases caused by Acinetobacter ursingii in a neonatal intensive care unit. Int J Med Microbiol. 2010;300:338–40. http://dx.doi.org/10.1016/j.ijmm.2009.10.007
7. Nemec A, Musílek M, Vaneechoute M, Falsen E, Dijkshoorn L. Lack of evidence for “Acinetobacter septicus” as a species different from Acinetobacter ursingii? J Clin Microbiol. 2008;46:2826–7. http://dx.doi.org/10.1128/JCM.01003-08
8. Dortet L, Legrand P, Soussy CJ, Cattoir V. Bacterial identification, clinical significance, and antimicrobial susceptibilities of Acinetobacter ursingii and Acinetobacter schindleri, two frequently misidentified opportunistic pathogens. J Clin Microbiol. 2006;44:4471–8. http://dx.doi.org/10.1128/JCM.01535-06
9. Endo S, Sasano M, Yano H, Inomata S, Ishibashi N, Aoyagi T, et al. IMP-1-producing carbapenem-resistant Acinetobacter ursingii from Japan. J Antimicrob Chemother. 2012;67:2533–4. http://dx.doi.org/10.1093/jac/dks249
10. Boo TW, Crowley B. Detection of blaOXA-58 and blaOXA- 23-like genes in carbapenem-susceptible Acinetobacter clinical isolates: should we be concerned? J Med Microbiol. 2009;58:839–41. http://dx.doi.org/10.1099/jmm.0.008904-0
11. van den Broek PJ, van der Reijden TJ, van Strijen E, Helmig-Schurter AV, Bernards AT, Dijkshoorn L. Endemic and epidemic Acinetobacter species in a university hospital, an eight years’ survey. J Clin Microbiol. 2009;47:3593–9. http://dx.doi.org/10.1128/JCM.00967-09
12. Turton JF, Shah J, Ozongwu C, Pike R. Incidence of Acinetobacter species other than A. baumannii among clinical isolates of Acinetobacter: evidence for emerging species. J Clin Microbiol. 2010;48:1445–9. http://dx.doi.org/10.1128/JCM.02467-09
13. Karah N, Haldorsen B, Hegstad K, Simonsen GS, Sundsfjord A, Samuelsen Ø; Norwegian Study Group of Acinetobacter. Species identification and molecular characterization of Acinetobacter spp. blood culture isolates from Norway. J Antimicrob Chemother. 2011;66:738–44. http://dx.doi.org/10.1093/jac/dkq521